Dennis Hom
No más puestos en curso
Fortuna: - $ al 31/05/2024
Historial de carrera de Dennis Hom
Antiguos cargos conocidos de Dennis Hom.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SAGIMET BIOSCIENCES INC. | Director Financiero/CFO | 01/10/2017 | 01/08/2023 |
| ACHAOGEN | Director Financiero/CFO | 01/01/2013 | 31/03/2014 |
| Contacto de Relaciones con Inversores | 01/01/2013 | 31/03/2014 | |
| Public Communications Contact | 01/01/2013 | 31/03/2014 | |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2011 | 01/01/2012 |
Formación de Dennis Hom.
| Massachusetts Institute of Technology | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Director of Finance/CFO | 2 |
| Investor Relations Contact | 1 |
| Public Communications Contact | 1 |
Sectorial
| Health Technology | 4 |
| Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| SAGIMET BIOSCIENCES INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Dennis Hom
- Experiencia
